UK-based Abcam, a developer and distributor of biological reagents and tools used in research, drug discovery and diagnostics, has opened a new 9,300m2 facility in Waltham, Massachusetts, US. The new site will operate as a hub for the company’s R&D and commercial activities in the region.

The facility is more than double the size of Abcam’s previous US site in the Kendall Square area of Cambridge. It is expected to eventually house 300 staff.

The opening will increase the company’s R&D, production, distribution and customer service capabilities to better serve the life sciences sector.

In a press release, chief executive officer Alan Hirzel stated: “Abcam’s first step toward global expansion was in 2003 at Kendall Square. Since then, the US has become our largest market. Investing in and expanding our presence in the vibrant Greater Boston cluster is another step in our journey to support biopharma partners and life sciences researchers globally in their quest to accelerate discovery and the translation of these discoveries into improved human health outcomes.”

The opening follows the establishment of a new cell engineering facility in Fremont, California, in December 2020.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.